Description
Romiplostim, marketed under the brand name ROMY, It is an prescription medication that has been approved romiplostim (Nplate) on August 22, 2008, for long-term treatment of chronic immune thrombocytopenia (ITP) in adults. On December 14, 2018, the FDA approved romiplostim for pediatric patients with ITP.
What is ROMY (Romidepsin) ?
Romidepsin blocks certain enzymes in the body and interferes with the growth of tumor cells. Romidepsin is used to treat T-cell lymphoma affecting the skin (cutaneous T-cell lymphoma, or CTCL). Romidepsin is usually given after other medicines have been tried without successful treatment of symptoms.
Romidepsin is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). Romidepsin is a natural product obtained from the bacterium Chromobacterium violaceum, and works by blocking enzymes known as histone deacetylases, thus inducing apoptosis.
How to order approved “ROMY (Romidepsin) for Injection” Medicine?
ROMY (Romiplostim) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing ROMY and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
